In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Assurant’s current price exceeds the PERT fair value by 15%, indicating potential overvaluation despite high analyst targets near the price. Financial health shows strong profitability but weak growth and liquidity, with high leverage adding risk. Monte Carlo results reveal substantial volatility and downside scenarios, reflecting elevated investment risk.